Zydus Lifesciences launches Revlimid generic – Lenalidomide Capsules in US

pallavi123- September 20, 2022 0

Indian pharma company Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited has launched Lenalidomide Capsules, a generic of Revlimid, in the US market. The ... Read More

Zydus Cadila gets FDA tentative approval for Cariprazine Capsules

pallavi123- December 12, 2021 0

Zydus Cadila said that its subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval from the US Food and Drug Administration (FDA) to commercialize Cariprazine Capsules ... Read More

Zydus Cadila gets FDA final approval for Decitabine injection

pallavi123- November 20, 2021 0

Zydus Cadila has secured final approval from the US Food and Drug Administration (FDA) for the commercialization of the cancer medication Decitabine for Injection in ... Read More

Cadila Healthcare bags order for 1cr ZyCoV-D vaccines from Indian govt

pallavi123- November 8, 2021 0

Cadila Healthcare (Zydus Cadila) has bagged an order from the Indian government to deliver one crore doses of its ZyCoV-D Plasmid DNA Covid-19 vaccine. According ... Read More

Zydus Cadila begins EVIDENCES-X phase 2b NASH trial of Saroglitazar Mg

pallavi123- October 23, 2021 0

Zydus Cadila (Cadila Healthcare) has dosed the first patient in the EVIDENCES-X phase 2b clinical trial of Saroglitazar Magnesium (Saroglitazar Mg) in non-alcoholic steatohepatitis (NASH). ... Read More

Zydus Cadila gets FDA tentative approval for acne treatment generic

pallavi123- October 9, 2021 0

Zydus Cadila has secured tentative approval from the US Food and Drug Administration (FDA) for marketing Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%. A generic of ... Read More

Zydus Cadila gets FDA approval for Apremilast Tablets

pallavi123- September 26, 2021 0

Zydus Cadila said that its subsidiary Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration (FDA) to market Apremilast Tablets, ... Read More

Zydus Cadila gets FDA’s final approval for Vortioxetine Tablets

pallavi123- September 19, 2021 0

Zydus Cadila has secured final approval from the US Food and Drug Administration (FDA) to market Vortioxetine Tablets in the strengths of 5mg, 10mg, 20mg ... Read More

Zydus Cadila gets FDA tentative approval for Sitagliptin base tablets

pallavi123- September 6, 2021 0

Zydus Cadila said that its subsidiary has been granted tentative approval from the US Food and Drug Administration (FDA) for its new drug application (NDA) ... Read More

Zydus Cadila gets FDA approval for Revlimid generic Lenalidomide Capsules

pallavi123- August 22, 2021 0

Zydus Cadila said that the US Food and Drug Administration (FDA) has granted it tentative approval for Lenalidomide Capsules, a generic version of Celgene Corporation’s ... Read More